GBR 12909 dihydrochloride
Chemical Name: 1-[2-[Bis-(4-fluorophenyl)methoxy]ethyl]-4-(3-phenylpropyl)piperazine dihydrochloride
Biological ActivityGBR 12909 dihydrochloride is a potent, competitive inhibitor of dopamine uptake (Ki = 1 nM for inhibition of striatal dopamine uptake). Has >100-fold lower affinity for the noradrenaline and 5-HT uptake carriers. Also a potent sigma ligand (IC50 = 48 nM). Centrally active following systemic administration.
The technical data provided above is for guidance only.
For batch specific data refer to the Certificate of Analysis.
Tocris products are intended for laboratory research use only, unless stated otherwise.
The DA uptake inhibitor GBR12909: selectivity and molecular mechanism of action.
GBR-12909 and fluspirilene potently inhibited binding of [3H] (+)3-PPP to sigma receptors in rat brain.
Contreras et al.
Life Sci., 1990;47:PL133
Behavioral properties of GBR 12909, GBR 13069 and GBR 13098: specific inhibitors of DA uptake.
Heikkila and Manzino
Pharmacological characterization of the discriminative-stimulus effects of GBR 12909.
Spealman and Melia
Citations for GBR 12909 dihydrochloride
The citations listed below are publications that use Tocris products. Selected citations for GBR 12909 dihydrochloride include:
12 Citations: Showing 1 - 10
Pharmacological Chaperones of the DA Transporter Rescue DA Transporter Deficiency Syndrome Mutations in Heterologous Cells.
Authors: Beerepoot Et al.
J Biol Chem 2016;291:22053
Spinal DArgic projections control the transition to pathological pain plasticity via a D1/D5-mediated mechanism.
Authors: Kim Et al.
J Neurosci 2015;35:6307
Dysfunctional DArgic neurotransmission in asocial BTBR mice.
Authors: Squillace Et al.
Transl Psychiatry 2014;4:e427
Enhanced synthesis and release of DA in transgenic mice with gain-of-function α6* nAChRs.
Authors: Wang Et al.
J Neurochem 2014;129:315
Soluble interleukin-6 receptor induces motor stereotypies and co-localizes with gp130 in regions linked to cortico-striato-thalamo-cortical circuits.
Authors: Patel Et al.
PLoS One 2012;7:e41623
Differential regulation of MeCP2 phosphorylation in the CNS by DA and serotonin.
Authors: Hutchinson Et al.
J Neurosci 2012;37:321
Progressive neurodegeneration or endogenous compensation in an animal model of Parkinson's disease produced by decreasing doses of alpha-synuclein.
Authors: Koprich Et al.
PLoS One 2011;6:e17698
The plasma membrane-associated GTPase Rin interacts with the DA transporter and is required for protein kinase C-regulated DA transporter trafficking.
Authors: Navaroli Et al.
J Neurosci 2011;31:13758
Expression of human A53T alpha-synuclein in the rat substantia nigra using a novel AAV1/2 vector produces a rapidly evolving pathology with protein aggregation, dystrophic neurite architecture and nigrostriatal degeneration with potential to model the pat
Authors: Koprich Et al.
Mol Neurodegener 2010;5:43
Impact of serotonin 2C receptor null mutation on physiology and behavior associated with nigrostriatal DA pathway function.
Authors: Abdallah Et al.
Br J Pharmacol 2009;29:8156
Electrophysiology and pharmacology of striatal neuronal dysfunction induced by mitochondrial complex I inhibition.
Authors: Costa Et al.
J Neurosci 2008;28:8040
PYM50028, a novel, orally active, nonpeptide neurotrophic factor inducer, prevents and reverses neuronal damage induced by MPP+ in mesencephalic neurons and by MPTP in a mouse model of Parkinson's disease.
Authors: Visanji Et al.
FASEB J 2008;22:2488
No product specific FAQs exist for this product, however you mayView all Small Molecule FAQs
VersaClone cDNA Plasmids
Reviews for GBR 12909 dihydrochloride
There are currently no reviews for this product. Be the first to review GBR 12909 dihydrochloride and earn rewards!
Have you used GBR 12909 dihydrochloride?
Submit a review and receive an Amazon gift card.
$25/€18/£15/$25CAN/¥75 Yuan/¥1250 Yen for a review with an image
$10/€7/£6/$10 CAD/¥70 Yuan/¥1110 Yen for a review without an image